How are patients (pts) with lower-risk myelodysplastic syndromes (MDS) treated? Impact on clinical evolution and overall survival: A report from the erasme study
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Fecha de publicación
2015Título de revista
Blood
Tipo de contenido
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)